Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BrickBio
AddedFeb 16, 2024
UpdatedJun 18, 2026
BrickBio

BrickBio

BrickBio develops a bioconjugation platform for optimized, site-specific protein modification research.

HQ
Boston, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize protein engineering, BrickBio focuses on developing a bioconjugation platform for site-specific protein modification. The company's innovative technology allows for the precise and selective modification of proteins, enhancing research capabilities in both prokaryotic and eukaryotic systems. Their platform is designed to optimize conjugates, providing researchers with advanced tools for protein engineering and therapeutic development.

BrickBio has garnered attention from notable investors and industry experts, contributing to its rapid growth and recognition within the biotech sector. The company's achievements include successful collaborations with leading research institutions and biotech firms, demonstrating the practical applications and benefits of their platform. BrickBio's impact is evident in its contribution to advancing protein engineering, offering significant potential for breakthroughs in medical research and drug development.

BrickBio - Similar Companies

Catena Biosciences logo

Catena Biosciences

BridGene Biosciences logo

BridGene Biosciences

Monod Bio logo

Monod Bio

monod.bio

Adaptyv Biosystems logo

Adaptyv Biosystems

adaptyvbio.com

Evozym Biologics logo

Evozym Biologics

Protillion Biosciences logo

Protillion Biosciences

protillion.com

Rbio logo

Rbio

rbio.online

BioHybrid Solutions logo

BioHybrid Solutions

Manifold Bio logo

Manifold Bio

manifold.bio

AI Proteins logo

AI Proteins

aiproteinstx.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

Vulcan Biologics logo

Vulcan Biologics

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

BrickBio - Quick Facts

Who are BrickBio's competitors?

Companies similar to BrickBio include Catena Biosciences, BridGene Biosciences, Monod Bio and Adaptyv Biosystems.

When was BrickBio founded?

BrickBio was founded in 2019.

Where is BrickBio's headquarters located?

BrickBio's headquarters is located in Boston, MA, US.

When was BrickBio's last funding round?

BrickBio's most recent funding round was for $5M (USD) in November 2019.

How much has BrickBio raised to-date?

As of Nov 22, 2019, BrickBio has raised a total of $5M (USD).

How many employees does BrickBio have?

BrickBio has 9 employees as of Feb 5, 2024.

BrickBio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Bioconjugation
  • Protein Engineering
Tags
  • Platform
  • Software
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 325412Pharmaceutical Preparation Manufacturing
  • 541511Custom Computer Programming Services
SIC
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 8000Health Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified